A study led by Columbia neurosurgeons has found that MRI-guided laser ablation is a viable treatment that can provide lasting seizure control for people with drug-resistant temporal lobe epilepsy.
Columbia and NewYork-Presbyterian research has shown that several genes implicated in rare forms of pediatric epilepsy also contribute to common forms of the disorder.
The annual suicide mortality rate among people with epilepsy is 22 percent higher than in the general population, Columbia University Medical Center researchers have found.
Two Columbia faculty are part of a 61-member international research team that discovered 25 epilepsy-causing mutations in new and previously identified genes.